Abnormal histopathology, fat percent and hepatic apolipoprotein A I and apolipoprotein B100 mRNA expression in fatty liver hemorrhagic syndrome and their improvement by soybean lecithin

Poult Sci. 2017 Oct 1;96(10):3559-3563. doi: 10.3382/ps/pex163.

Abstract

To investigate the etiopathogenesis of fatty liver hemorrhagic syndrome (FLHS) and the protective effects of soybean lecithin against FLHS in laying hens, 135 healthy 300-day-old Hyline laying hens were randomly divided into groups: control (group 1), diseased (group 2), and protected (group 3). Each group contained 45 layers with 3 replicates. The birds in these 3 groups were fed a control diet, a high-energy/low-protein (HELP) diet or the HELP diet supplemented with 3% soybean lecithin instead of maize. The fat percent in the liver was calculated. Histopathological changes in the liver were determined by staining, and the mRNA expression levels of apolipoproteinA I (apoA I) and apolipoprotein B100 (apoB100) in the liver were determined by RT-PCR. The results showed that the fat percent in the liver of group 2 was much higher (P < 0.01) than that of group 1 and group 2 on d 30 and 60. The histology of the liver in group 2 on d 30 and 60 displayed various degrees of liver lesions, while the hepatocytes showed a normal structure in group 3 with mild microvesicular steatosis in the liver cell on d 30 and 60. The mRNA expression levels of apoA I and apoB100 in the livers were variable throughout the experiment. The expression level of apoA I in group 2 significantly decreased on d 60 (P < 0.05); the expression level of apoB100 slightly increased on d 30 in group 2, while it sharply decreased on d 60. Compared to group 1, the expression level of apoB100 showed no significant difference in group 3 (P < 0.05). This study indicated that FLHS induced pathological changes and abnormal expression of apoA I and apoB100 in the livers of laying hens and that soybean lecithin alleviated these abnormal changes.

Keywords: Soybean lecithinfatty; apolipoprotein A I; apolipoprotein B100; fatty liver hemorrhagic syndrome; high-energy low-protein diet.

MeSH terms

  • Animal Feed / analysis
  • Animals
  • Apolipoprotein A-I / genetics*
  • Apolipoprotein A-I / metabolism
  • Apolipoprotein B-100 / genetics*
  • Apolipoprotein B-100 / metabolism
  • Avian Proteins / genetics*
  • Avian Proteins / metabolism
  • Body Fat Distribution
  • Chickens*
  • Diet / veterinary
  • Dietary Supplements / analysis
  • Fatty Liver / drug therapy
  • Fatty Liver / metabolism
  • Fatty Liver / physiopathology
  • Fatty Liver / veterinary*
  • Female
  • Glycine max / chemistry
  • Lecithins / administration & dosage
  • Lecithins / metabolism*
  • Liver / metabolism
  • Liver / physiopathology
  • Poultry Diseases / drug therapy
  • Poultry Diseases / metabolism
  • Poultry Diseases / physiopathology*
  • Random Allocation

Substances

  • Apolipoprotein A-I
  • Apolipoprotein B-100
  • Avian Proteins
  • Lecithins